Skip to content

Bone marrow mononuclear cells combined with beta-tricalcium phosphate granules for craniofacial bone defect repair: a randomized, traditional surgical controlled trial

Bone marrow mononuclear cells combined with beta-tricalcium phosphate granules for craniofacial bone defect repair: a randomized, traditional surgical controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020556
Enrollment
Unknown
Registered
2019-01-08
Start date
2019-01-08
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alveolar cleft

Interventions

Experiment Group:Bone marrow mononuclear cells combined with beta-tricalcium phosphate granules
Control Group:Autologous iliac crest bone graft

Sponsors

Plastic Surgery Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 8 to 12 years; 2. Diagnosed as unilateral cleft lip or Cleft lip and palate combined by alveolar cleft. The Cleft lip and palate have been repaired; 3. No alveolar cleft repair or Gingival periosteoplasty was performed before; 4. No orthodontic treatment was performed before; 5. The patient's guardian agreed to participate in the experiment and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Bilateral cleft lip or cleft lip and palate; 2. Combined with palatal fistula which requiring surgical repair; 3. Definitely diagnosed as well-known syndrome or combined with other craniofacial deformities besides cleft lip and palate; 4. Orthodontic treatment is demanded before bone grafting or conventional single treatment is insufficient for the repair of alveolar bone defect; 5. Intolerance to general anesthesia evaluated by preoperative examination and assessment or not suitable for surgery by other causes; 6. Poorly compliance to preoperative evaluation or examinations during the whole experimental period; 7. Patients with a history or examnation of bone metabolic disorders that may affect bone healing process (Such as osteoporosis, osteomalacia, etc.); 8. Allergic constitution, or with clear allergic history of related materials, reagents and drugs; 9. Alcohol or drug addicts; 10. Those who are participating in other clinical trials and have not reached the end point.

Design outcomes

Primary

MeasureTime frame
Bone formation ratio;

Secondary

MeasureTime frame
Chelsea scale;Luwei Liu and Lian Ma’s scale;Pain intensity rating scales;Total operative time and total blood loss;

Countries

China

Contacts

Public ContactRan Xiao

Plastic Surgery Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

xiaoran@psh.pumc.edu.cn+86 10 5396 8227

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026